Leading Advancements in the Uptake of Newborn Community Health (LAUNCH)

March 18, 2024 updated by: Brandon Guthrie, University of Washington

Leading Advancements in the Uptake of Newborn Community Health (LAUNCH)

The primary objective of the study is to determine the impact of a behavior change intervention that partners Orthodox priests with members of the Health Development Army (HDA) and train them to conduct newborn health outreach to increase rates of early initiation of and exclusive breastfeeding through 6 months and vaccination coverage at six months.

Secondary objectives include:

  • Determine the impact of the intervention on infant growth at six months, observed and self-reported changes in nutrition and feeding practices of mother and infants, and early identification of newborn illness.
  • Design a culturally relevant, scalable intervention for community-based newborn and infant health in Gondar in partnership with local partners, the Federal Ministry of Health, and the Gondar Regional Health Bureau.

Study Overview

Detailed Description

The study will test a model the leverages existing community networks to improve the health of newborns in Gondar, Ethiopia. The intervention will be implemented at the community level by pairs of trained Ethiopian Orthodox priests and members of the Heath Development Army (HDA). A list of priests serving at the EOC churches in the intervention arm will be obtained through the woreda diocese and their respective churches. All the priests will be contacted through the church leadership and asked to participate in the study intervention. The intervention will be implemented in collaboration with HDA members recruited by HEWs under the health centers in the catchment areas of the intervention churches.

An initial 5 day training will be given to priests and HDA members. The training will focus on newborn health topics including early initiation of and exclusive breastfeeding, maternal nutrition, immunization, childhood illnesses, child health care services, etc. At the end of the training action plans will be prepared by the training organizers, priests, and HDA. Priest will be asked to integrate health messages and education into their routine family visits around the birth of a child in structured intervals as culturally appropriate.

The trained priests and HDA members will be dispatched to their respective communities to begin the intervention. Their primary activities will be identification of near-term pregnant and newly delivered women, providing health education to their families, follow-up visits to enable newborn-mother pairs to access child health care services, and to provide health education at religious and community gatherings. Specifically, pre-planned visits of parishioners' families will be done by the respective priests and the partnering HDA members during the last month of pregnancy, immediately after the delivery of the baby and around the time of baptism for the newborn. These visits will be used to educate pregnant and postpartum women and their families on newborn health topics including initiation of breastfeeding, duration of breastfeeding/ exclusive breastfeeding, vaccination, cord care, and utilization of available newborn health care services. These community based activities will be monitored through regular follow-up visits by the UoG study team and discussions with priests and HDA members.

Newborn-mother pairs will be recruited within the first 10 days after delivery as reported to the study team by Health Extension Workers (HEWs) engaged in the study. Recruitment will start one month following the start of the intervention and all reported newborn-mother pairs who meet the screening criteria will be included in the study until the calculated sample sizes are reached. HEW's routine registers of new deliveries will be used to trace, recruit and screen study participants. Newborn-mother pairs who fulfill an initial screening criteria will be reported to the study team at the University of Gondar (UoG) who will travel to the study site regularly for recruitment of study participants and data collection. Newborn-mother pairs will be reported to the UoG study team both through phone calls made by HEWs and in-person at the time of regular onsite visits by the team.

Newborn-mother pairs will be recruited within the first 10 days after delivery as reported to the study team by Health Extension Workers (HEWs) engaged in the study. Recruitment will start one month following the start of the intervention and all reported newborn-mother pairs who meet the screening criteria will be included in the study until the calculated sample sizes are reached. HEW's routine registers of new deliveries will be used to trace, recruit and screen study participants. Newborn-mother pairs who fulfill an initial screening criteria will be reported to the study team at the University of Gondar (UoG) who will travel to the study site regularly for recruitment of study participants and data collection. Newborn-mother pairs will be reported to the UoG study team both through phone calls made by HEWs and in-person at the time of regular onsite visits by the team.

Eligible newborn-mother pairs will be visited by a member of the study team at their home or at an appointed meeting location in their community to complete the verbal informed consent process. Those pairs who attend church at a parish that received the intervention will be assigned to the intervention arm, and those from the parishes where no intervention was conducted will be assigned to the control arm. Initial baseline data will then be collected and follow-up visit schedules arranged with the study team.

Study Type

Interventional

Enrollment (Actual)

316

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Amhara
      • Gondar, Amhara, Ethiopia, P.O. Box 126
        • University of Gondar

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 49 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Newborn-mother pairs visited by the study staff (Enrolled women and newborns)

The following inclusion criteria will be used during recruitment:

  • Newborns should be those delivered at least one month after the start of the intervention period
  • Newborn-mother pairs should be EOC parishioners
  • Newborn's family should have a soul father (a spiritual advisor assigned to the family in the Ethiopian Orthodox tradition)
  • Mother must have lived in the study area for at least 6 months
  • Mothers must give written informed consent for themselves and their newborn

Formative focus group discussion and key informant interview participants (FGD and KII participants)

The following inclusion criteria will be used during recruitment:

  • Mothers of newborns <6 months old
  • Fathers of newborn children <6 months
  • Ethiopian Orthodox priests from the North Gondar region
  • Healthcare workers from government Health Centers (unit of primary care)
  • All participants must have established residency in the region for >6 months
  • All participant must give verbal informed consent

Exclusion Criteria:

Newborn-mother pairs visited by the study staff (Enrolled women and newborns)

The following exclusion criteria will be used during recruitment:

  • Newborns with gross developmental abnormalities that would make anthropometric measurements and interpretations difficult
  • Newborns identified by the study team as in distress and in need of immediate, emergency care during the enrollment visit
  • Newborn whose mother is not a member of an EOC parish
  • Newborns whose mothers have died by the time of recruitment
  • Newborn whose family plans to re-locate away from the study site in less than 6 months
  • Newborns who were part of a multiple birth but are not the first born should be excluded

Formative focus group discussion and key informant interview participants (FGD and KII participants)

The following exclusion criteria will be used during recruitment:

- Newly established residence in the Woreda (<6 months)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Community influencers will receive training and give community education to women and their families regarding newborn health.
No Intervention: Control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mid-upper arm circumference
Time Frame: Up to six months
Anthropometric Measurement using MUAC tapes
Up to six months
Proportion of mothers exclusive breastfeeding
Time Frame: Up to six months
Self-reported breastfeeding behavior
Up to six months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Immunization status
Time Frame: Up to six months
Collected from vaccination cards
Up to six months
Frequency of acute illness
Time Frame: Up to six months
Self reported
Up to six months
Frequency of hospitalization status
Time Frame: Up to six months
Self reported
Up to six months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Brandon Guthrie, PhD, University of Washington

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 11, 2022

Primary Completion (Actual)

August 22, 2023

Study Completion (Estimated)

April 1, 2024

Study Registration Dates

First Submitted

July 26, 2021

First Submitted That Met QC Criteria

October 26, 2021

First Posted (Actual)

November 8, 2021

Study Record Updates

Last Update Posted (Actual)

March 20, 2024

Last Update Submitted That Met QC Criteria

March 18, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STUDY00006942

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breastfeeding, Exclusive

Clinical Trials on Newborn Health Education

Subscribe